Drug profile · INN
phentolamine mesylate
PHENTOLAMINE MESYLATE
phentolamine mesylate (PHENTOLAMINE MESYLATE) is a adrenergic receptor alpha antagonist. Associated with Chongqing Precision Biotech Co., Ltd. Route of administration: ophthalmic. Current US regulatory status: approved.
Drug details — phentolamine mesylate
- US status
- approved
- Class
- —
- Route
- OPHTHALMIC
- Patents
- 0
- Programs
- 0
- Data quality
- 0.89
Quick answer
phentolamine mesylate (PHENTOLAMINE MESYLATE) is a adrenergic receptor alpha antagonist. Associated with Chongqing Precision Biotech Co., Ltd. Route of administration: ophthalmic. Current US regulatory status: approved.
Key facts
Mechanism of action
Adrenergic receptor alpha antagonist
Primary target: Adrenergic receptor alpha
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is phentolamine mesylate?
phentolamine mesylate (PHENTOLAMINE MESYLATE) is a adrenergic receptor alpha antagonist. Associated with Chongqing Precision Biotech Co., Ltd. Route of administration: ophthalmic. Current US regulatory status: approved.
What is the brand name for phentolamine mesylate?
PHENTOLAMINE MESYLATE is a marketed brand name for phentolamine mesylate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of phentolamine mesylate?
phentolamine mesylate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.